Gaspar DeViedma, Health Robotics’ Executive Vice President, stated: “As we started supporting regional events in 2013 with the
At the New York Pharmacy Technology Summit in
Mr. DeViedma continued: “One competitor (Intelligent Hospital Systems-RIVA) routinely claims to be the only robot with “true walk-away capabilities”, which is utter nonsense considering that even old IV Robots have had this feature for decades. In my opinion, this hype only demonstrates that it takes RIVA’s users so long to load and so long to process IV doses that they truly have to “walk away” and come back several hours later or even the next day in order to retrieve the IV output. This IHS “unattended” claim is also counterintuitive to the same company’s claim that it takes 1.5 FTEs to support RIVA. What are the 1.5 RIVA FTEs necessary for, if this is true? Similarly, another competitor (APOTECAchemo) routine propaganda was widely exposed2 for its ongoing problems at the
Overwhelmingly, pharmacists continue to recognize the undeniable fact that Health Robotics’ Second Generation architecture of integrated and networked medical devices are fully-automated, with automatic labeling and tamper-resistant capping, offering 3 to 4 times faster speed/throughput, for less than half the price, size, and weight than its major competitors1, while delivering payback periods/R.O.I. ranging from 6 months for i.v.STATION to 1.5 years for i.v.STATION ONCO.
About Health Robotics:
Founded in 2006, Health Robotics is the undisputed leading supplier of life-critical sterile compounding Robots with greater than 80% total IV Robots market share in the world [including over 90% the Oncology Robots global market]. Health Robotics provides near 600 hospital installations in 5 continents with the only fully integrated, robotics-based technology, IV Workflow, and manual compounding software automation solutions. Health Robotics’ second-generation-platform products [i.v.STATION®, i.v.SOFT®, i.v.STATION® ONCO, and i.v.STATION® 2 for TPNs] have been proven [through scientific and peer-reviewed studies3, 4, 5] to greatly contribute to ease hospitals’ growing pressures to improve patient safety3, increase throughput3, and contain costs3. Through the effective and efficient production of sterile, accurate, tamper-evident, and ready-to-administer IVs and TPNs, Health Robotics’ medical devices and integrated workflow solutions help hospitals eliminate life-threatening drug3 and diluent exchange errors, improve drug potency4, decrease other medical mistakes3 and sterility risks, work more efficiently3, reduce waste3 and controlled substances’ diversion, decrease pharmacy technician upper-limb injuries5, and diminish the gap between rising patient volume/acuity and scarce nursing and pharmacy staff3.
1 Competitors: Intelligent Hospital Systems/RIVA, Fresenius Kabi/MDS, Baxter/Baxa, and Loccioni.
2Implementation of an i.v.-compounding robot in a hospital-based cancer center pharmacy; Am J Health Syst Pharm
3Impact of Robotic Antineoplastic Preparation on Safety, Workflow, Costs.
4Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin®, Remicade®, and Herceptin®. Peters, Capelle, Arvinte,
5Comparing the upper limb disorder risks associated with manual and automated cytotoxic compounding. McLeod, Zochowska, Leonard, Crow, Jacklin, Dean, Franklin.
Source: Health Robotics
Most Popular Stories
- Top Hispanic Tech Companies Push for the Top
- 5 Notable Hispanic Technology Executives
- FAA to Appeal Court Decision Allowing Commercial Drone Use
- Tesla's Alt-Energy Future Aims for Massive Lithium-Ion Battery Production
- Rand Paul Tops Presidential Straw Poll at Conservative PAC Conference
- California Establishes Center for Coffee Study
- Sunday Starts Daylight Saving Time
- New Chat App, Yik Yak, Causes Problems for Students
- Taco Bell Rings Up Breakfast Menu
- Gas Prices May Jump from Calif. Emissions Law